Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
28 studies found for:    ICHTHYOSIS, X-LINKED
Show Display Options
RSS Create an RSS feed from your search for:
ICHTHYOSIS, X-LINKED
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  National Registry for Ichthyosis and Related Disorders
Conditions: Darier Disease;   Hailey-Hailey Disease;   Hyperkeratosis, Epidermolytic;   Ichthyosis;   Ichthyosis, Lamellar;   Ichthyosis, X-Linked;   Keratoderma
Intervention:
2 Recruiting STS/ACC Transcatheter Valve Therapy Registry (TVT Registry)
Condition: Aortic Valve Stenosis
Intervention: Procedure: Transcatheter Aortic Valve Replacement
3 Active, not recruiting Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)
Conditions: Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor;   Malignant Fibrous;   Histiocytoma/Undifferentiated Pleomorphic Sarcoma
Intervention: Drug: Gemcitabine and Docetaxel in Combination with Pazopanib
4 Completed Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS)
Conditions: Gastrointestinal Stromal Tumors;   Soft Tissue Sarcomas
Intervention: Drug: IPI-504
5 Recruiting Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Pazopanib
6 Unknown  Contribution of F18-FDG PET/CT to the Early Assessment of Pazopanib Therapy Efficacy in Advanced Soft Tissue Sarcoma
Condition: Soft Tissue Sarcoma (STS)
Intervention: Other: F18-FGD PET/CT
7 Recruiting STS/ACC TVT Registry Mitral Module
Condition: Mitral Valve Regurgitation
Intervention: Device: Leaflet Clip
8 Active, not recruiting A Phase II Study of Anlotinib Hydrochloric Capsule in STS Patients
Condition: Cancer
Intervention: Drug: Anlotinib Hydrochloric Capsule
9 Completed Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Intervention: Drug: Bendamustin
10 Active, not recruiting Trofosfamide Versus Adriamycin in Elderly Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Trofosfamide
11 Active, not recruiting
Has Results
Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)
Condition: Soft Tissue Sarcoma
Interventions: Procedure: External Beam Radiation Therapy (RT);   Biological: Autologous Dendritic Cells
12 Completed Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS)
Condition: Sarcoma, Soft Tissue
Interventions: Drug: Adriamycin;   Drug: Ifosfamide;   Drug: Etoposide;   Drug: Carboplatin
13 Recruiting Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide
Condition: Soft Tissue Sarcoma
Intervention:
14 Unknown  Study on Efficacy and Tolerability of Vorinostat in Patients With Advanced, Metastatic Soft Tissue Sarcoma (STS)
Condition: Soft Tissue Sarcoma
Intervention: Drug: Vorinostat
15 Withdrawn A Pilot Study to Evaluate Topical Sodium Thiosulfate Therapy for Calcinosis Cutis
Condition: Calcinosis Cutis
Interventions: Drug: Sodium thiosulfate;   Drug: Placebo
16 Completed Selegiline for Smoking Cessation - 1
Condition: Nicotine Dependence
Intervention: Drug: Selegiline
17 Completed Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients
Conditions: Cognition Disorders;   HIV Infections
Intervention: Drug: Selegiline hydrochloride
18 Recruiting Trabectedin First Line Therapy In Unfit Sarcoma Study
Conditions: Metastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive;   Standard Chemotherapy
Intervention: Drug: Trabectedin
19 Completed Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma
Condition: Sarcoma
Intervention: Drug: soblidotin
20 Recruiting Phase II Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Soft Tissue Sarcomas.
Condition: Locally Advanced or Metastatic Soft Tissue Sarcoma
Interventions: Drug: NGR-hTNF;   Drug: Doxorubicin

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years